 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C25H29N3O3 |
| Molar mass | 419.525 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Adimolol (developmental code name MEN-935) is antihypertensive agent which acts as a non-selective α1-, α2-, and β-adrenergic receptor antagonist.[1]
The reaction between 1-naphthyl glycidyl ether (1) and 3-(3-amino-3-methylbutyl)-1H-benzimidazol-2-one (2) gives adimolol (3).[2][3]
|
| |||||
|---|---|---|---|---|---|
| Sympatholytics (antagonize α-adrenergic vasoconstriction) |
| ||||
| Other antagonists |
| ||||
| |||||
|
| |||||
|---|---|---|---|---|---|
| α1 |
| ||||
| α2 |
| ||||
| β |
| ||||
| |||||
 | This article about an amine is a stub. You can help Wikipedia by expanding it. |
 | This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
